Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Influenza Vaccines Efficacy and Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT07229820
What this trial is testing

Efficacy and Safety of ZSP1273 in Children 12-17 Years Old With Influenza A

Who this might be right for
Influenza A
Guangdong Raynovent Biotech Co., Ltd 157
Testing effectiveness (Phase 2)Ended earlyNCT03511066
What this trial is testing

Evaluate the Efficacy and Safety of CT-P27 in Acute Uncomplicated Influenza A Infection

Who this might be right for
Influenza A
Celltrion 228
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07503405
What this trial is testing

Phase 2a Study of the Efficacy and Safety of TRX-100 in a Human Influenza A Challenge Model

Who this might be right for
Influenza
Traws Pharma, Inc. 165
Testing effectiveness (Phase 2)Looking for participantsNCT06684379
What this trial is testing

Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm in Patients With Acute Respiratory Infection Caused by SARS-Cov-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV)

Who this might be right for
SARS-CoV-2Influenza, HumanRespiratory Syncytial Virus Infections+2 more
PEACHES BIOTECH 50
Testing effectiveness (Phase 2)Study completedNCT05523089
What this trial is testing

The Effectiveness of CD388 to Prevent Flu in an Influenza Challenge Model in Healthy Adults

Who this might be right for
Influenza
Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 59
Early research (Phase 1)Looking for participantsNCT06355232
What this trial is testing

Covid-19 and Influenza Oral Vaccine Study

Who this might be right for
covid19 InfectionInfluenza, Human
Vaxine Pty Ltd 100
Large-scale testing (Phase 3)Ended earlyNCT05170009
What this trial is testing

Baloxavir in Combination With Oseltamivir in Allogenic Bone Marrow Transplant Recipients With Influenza

Who this might be right for
Influenza
Weill Medical College of Cornell University 2
Large-scale testing (Phase 3)Study completedNCT03739112
What this trial is testing

Efficacy of a Plant-derived Quadrivalent Virus-like Particle (VLP) Vaccine in the Elderly

Who this might be right for
Virus DiseasesRNA Virus InfectionsRespiratory Tract Diseases+1 more
Medicago 12,794
Not applicableStudy completedNCT03061955
What this trial is testing

Safety and Efficacy of Concurrent Administration of Influenza Vaccine in Patients Undergoing Anti-PD-1 Immunotherapy (Nivolumab, Pembrolizumab)

Who this might be right for
Influenza Virus Vaccine Adverse Reaction (Disorder)InfluenzaMalignancy
Wake Forest University Health Sciences 28
Large-scale testing (Phase 3)Looking for participantsNCT07626437
What this trial is testing

Fixed-dose Combination of 1000 mg Dipyrone Monohydrate + 60 mg Caffeine + 4 mg Chlorpheniramine Maleate in Improving Symptoms of the Common Cold and Flu in Adults

Who this might be right for
Common Cold/FluNasal CongestionNasal Obstruction
Brainfarma Industria Química e Farmacêutica S/A 620
Post-approval studies (Phase 4)Study completedNCT01850446
What this trial is testing

Comparative Clinical Trial of Efficacy and Safety of Ergoferon Versus Oseltamivir in Treatment of Influenza

Who this might be right for
Influenza
Materia Medica Holding 184
Post-approval studies (Phase 4)Study completedNCT03410862
What this trial is testing

Evaluating The Safety And Clinical Efficacy Of Elderberry Extract In Patients With Influenza

Who this might be right for
Influenza, Human
michael macknin 87
Testing effectiveness (Phase 2)Study completedNCT00197301
What this trial is testing

Liposomal Based Intranasal Influenza Vaccine:Safety and Efficacy

Who this might be right for
Influenza
Hadassah Medical Organization 200
Large-scale testing (Phase 3)Study completedNCT00539864
What this trial is testing

Safety and Reactogenicity of FluBlok and Comparison of Immunogenicity, Efficacy and Effectiveness Against TIV

Who this might be right for
Influenza
Protein Sciences Corporation 602
Testing effectiveness (Phase 2)UnknownNCT01006681
What this trial is testing

Vaccination Against Influenza H1N1 in Rheumatic Diseases

Who this might be right for
InfluenzaRheumatic Diseases
Tel-Aviv Sourasky Medical Center 400
Large-scale testing (Phase 3)Study completedNCT01158326
What this trial is testing

Evaluation of Efficacy and Safety of Oral Solution Resfenol in Reducing Symptoms of Common Cold And Flu

Who this might be right for
Common ColdInfluenza
Hospital de Clinicas de Porto Alegre 216
Testing effectiveness (Phase 2)Study completedNCT03455491
What this trial is testing

Study to Assess Efficacy and Safety of XC221 in the Treatment of Influenza and Other Acute Respiratory Viral Infections

Who this might be right for
Acute Respiratory Viral InfectionsInfluenza
PHARMENTERPRISES LLC 120
Testing effectiveness (Phase 2)Looking for participantsNCT07633288
What this trial is testing

A Clinical Trial Evaluating the Safety and Efficacy of AP1189 Versus Placebo as an add-on to Standard of Care in Participants With Respiratory Insufficiency Expected to be Caused by Infection With Respiratory Viruses

Who this might be right for
Respiratory Viral Infection
SynAct Pharma Aps 96
Post-approval studies (Phase 4)Study completedNCT01499914
What this trial is testing

Cohort Study Evaluating the Clinical Effectiveness, Safety and Immunogenicity to the Pandemic Influenza Vaccination

Who this might be right for
Cystic Fibrosis With Gastrointestinal Manifestation
Assistance Publique - Hôpitaux de Paris 439
Large-scale testing (Phase 3)Study completedNCT02572817
What this trial is testing

Comparing the Efficacy and Safety of High-Titer Versus Low-Titer Anti-Influenza Immune Plasma for the Treatment of Severe Influenza A

Who this might be right for
Influenza A Virus Infection
National Institute of Allergy and Infectious Diseases (NIAID) 138
Next Page